CCM
KLRS

CAAS Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

CAAS Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,870
Closed -$850K – 461
2023
Q2 		$850K Buy
+10,870
New +$850K 0.06% 47
2020
Q4 		– Sell
-1,087
Closed -$688K – 646
2020
Q3 		$688K Buy
+1,087
New +$688K 0.02% 205